These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

135 related items for PubMed ID: 4447697

  • 1. [Action of a peripheral inhibitor of dopa-decarboxylase on the inhibition by L-DOPA of the hypothalamo-hypophyseo-adrenocortical system in man].
    Balestreri R, Bertolini S, Elicio N, Costa S.
    Boll Soc Ital Biol Sper; 1974 Jul 30; 50(12):832-7. PubMed ID: 4447697
    [No Abstract] [Full Text] [Related]

  • 2. [Inhibition by L-DOPA of the hypothalamo-hypophyseo-adrenocortical response to insulin hypoglycemia in man].
    Balestreri R, Bertolini S, Elicio N, Rotella A.
    Boll Soc Ital Biol Sper; 1974 Jul 30; 50(12):838-44. PubMed ID: 4447698
    [No Abstract] [Full Text] [Related]

  • 3. [Observations on the effect of L-dopa on the hypothalamo-hypophyseal-adrenocortical axis in humans].
    Balestreri R, Bertolini S, Elicio N.
    Boll Soc Ital Biol Sper; 1974 Apr 15; 50(7):397-403. PubMed ID: 4441436
    [No Abstract] [Full Text] [Related]

  • 4. [Disulfiram and inhibition by L-dopa of the hypothalamo-hypophyseal-adrenocortical system during hypoglycemic stress in humans].
    Bertolini S, Elicio N, Costa S, Balestreri R.
    Boll Soc Ital Biol Sper; 1975 Feb 28; 51(4):184-8. PubMed ID: 1203115
    [No Abstract] [Full Text] [Related]

  • 5. [Effect of alpha-methyldopa on the inhibition by L-dopa of the hypothalamo-hypophyseal-adrenocortical system during hypoglycemic stress in humans].
    Bertolini S, Elicio N, Costa S, Balestreri R.
    Boll Soc Ital Biol Sper; 1975 Feb 28; 51(4):178-83. PubMed ID: 1203114
    [No Abstract] [Full Text] [Related]

  • 6. [Glucagon and function of the hypothalamo-hypophyseal-adrenocortical system in humans].
    Balestreri R, Bertolini S, Elicio N, Costa S.
    Boll Soc Ital Biol Sper; 1974 Apr 15; 50(7):417-23. PubMed ID: 4441438
    [No Abstract] [Full Text] [Related]

  • 7. [Action of L-dopa on the response of the hypothalamo-hypophyseal-adrenocortical system to insulin-induced hypoglycemia in normal and obese subjects].
    Bertolini S, Elicio N, Costa S, Balestreri R.
    Boll Soc Ital Biol Sper; 1975 Feb 28; 51(4):189-95. PubMed ID: 1203116
    [No Abstract] [Full Text] [Related]

  • 8. [On the influence of haloperidol on the hypothalamo-hypophyseal-adrenocortical axis in humans].
    Balestreri R, Bertolini S, Elicio N.
    Boll Soc Ital Biol Sper; 1974 Apr 15; 50(7):404-9. PubMed ID: 4441437
    [No Abstract] [Full Text] [Related]

  • 9. [On the effect of 5-hydroxytryptophan on the hypothalamo-hypophyseal-adrenocortical axis in humans].
    Balestreri R, Bertolini S, Elicio N.
    Boll Soc Ital Biol Sper; 1974 Apr 15; 50(7):410-6. PubMed ID: 4548354
    [No Abstract] [Full Text] [Related]

  • 10. [Hypothalamo-hypophysal-adrenal interrelations following administration of L-DOPA in patients with Itsenko-Cushing disease and diencephalic obesity].
    Marova EI, Safronova NA, Butrova SA, Bol'shakova TD, Tiabenkova VF.
    Sov Med; 1977 Jun 15; (6):70-5. PubMed ID: 897784
    [No Abstract] [Full Text] [Related]

  • 11. [Attempt at potentiation of the action of L-dopa on the secretion of growth hormone by benserazide, disulfiram and propranolol].
    Rochiccioli P, Enjaume P, Dutau G, Ribot C, Augier D.
    Arch Fr Pediatr; 1976 Jan 15; 33(1):55-66. PubMed ID: 985031
    [Abstract] [Full Text] [Related]

  • 12. Influence of adrenergic blocking agents on lysine-vasopressin induced plasma cortisol response in man.
    Cugini P, Rossi G, Giovannini C, Scavo D.
    Folia Endocrinol; 1974 Dec 15; 27(6pt2):678-84. PubMed ID: 4157150
    [No Abstract] [Full Text] [Related]

  • 13. [Comparative studies of L-DOPA alone and combination with a peripheral DOPA decarboxylase inhibitor, benserazide-HCl, on Parkinson's disease--Part II: Pharmacokinetic study (author's transl)].
    Yokochi M, Kondo T, Hirayama K, Narabayashi H, Kuruma I.
    No To Shinkei; 1979 Apr 15; 31(4):339-48. PubMed ID: 454549
    [No Abstract] [Full Text] [Related]

  • 14. [Variation in the levels of biogenic amines in the central and peripheral nervous system of rats with portacaval anastomoses after the administration of levodopa].
    Arias J, Alsasua A, Estebánez E, López Sánchez ML, Arias JI, Durán M, Garciá de Jalón PD, Durán Sacristan H.
    Rev Esp Enferm Apar Dig; 1982 Mar 15; 61(3):195-201. PubMed ID: 6125002
    [No Abstract] [Full Text] [Related]

  • 15. Corticosteroid-induced suppression of the hypothalamo-pituitary-adrenal axis: observations on patients given oral corticosteroids for rheumatoid arthritis.
    Jasani MK, Boyle JA, Greig WR, Dalakos TG, Browning MC, Thompson A, Buchanan WW.
    Q J Med; 1967 Jul 15; 36(143):261-76. PubMed ID: 6049762
    [No Abstract] [Full Text] [Related]

  • 16. The effect of L-dopa on peripheral sympathetic nerve function: role of presynaptic dopamine receptors.
    Lokhandwala MF, Buckley JP.
    J Pharmacol Exp Ther; 1978 Feb 15; 204(2):362-71. PubMed ID: 621670
    [No Abstract] [Full Text] [Related]

  • 17. [Dopaminergic control of the diencephalo-pituitary axis for somatotropin secretion].
    Cavagnini F, Pontiroli AE, Raggi U, Peracchi M, Malinverni A.
    Folia Endocrinol; 1973 Dec 15; 26(6):483-9. PubMed ID: 4801258
    [No Abstract] [Full Text] [Related]

  • 18. [Growth hormone secretion induced by L-Dopa and a dopa decarboxylase inhibitor blocked by free fatty acids].
    Casanueva F, Villanueva L, Peñalva A, Barrionuevo JA, Vila T, Cabezas-Cerrato J.
    Rev Clin Esp; 1979 May 15; 153(3):221-4. PubMed ID: 482695
    [No Abstract] [Full Text] [Related]

  • 19. [Effect of VB6 on L-DOPA decarboxylase activity in the organs of rats given peripheral L-DOPA decarboxylase inhibitors (author's transl)].
    Yoshimine N, Kuzuya F, Mori K, Sakamoto N.
    Nihon Ronen Igakkai Zasshi; 1978 Nov 15; 15(6):566-73. PubMed ID: 732010
    [No Abstract] [Full Text] [Related]

  • 20. L-3,4-dihydroxyphenylalanine-induced c-Fos expression in the CNS under inhibition of central aromatic L-amino acid decarboxylase.
    Shimamura M, Shimizu M, Yagami T, Funabashi T, Kimura F, Kuroiwa Y, Misu Y, Goshima Y.
    Neuropharmacology; 2006 Jun 15; 50(8):909-16. PubMed ID: 16504219
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.